xylometazoline has been researched along with Chronic Disease in 7 studies
xylometazoline: RN given refers to parent cpd; structure
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Excerpt | Relevance | Reference |
---|---|---|
"The addition of fluticasone to xylometazoline and antimicrobial therapy with cefuroxime improves clinical success rates and accelerates recovery of patients with a history of chronic rhinitis or recurrent sinusitis who present for treatment of acute rhinosinusitis." | 9.09 | Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. ( Califf, RM; Dolor, RJ; Hellkamp, AS; Simel, DL; Williams, JW; Witsell, DL, 2001) |
"The addition of fluticasone to xylometazoline and antimicrobial therapy with cefuroxime improves clinical success rates and accelerates recovery of patients with a history of chronic rhinitis or recurrent sinusitis who present for treatment of acute rhinosinusitis." | 5.09 | Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. ( Califf, RM; Dolor, RJ; Hellkamp, AS; Simel, DL; Williams, JW; Witsell, DL, 2001) |
"Whether nasal congestion promotes obstructive sleep apnea is controversial." | 2.73 | Does nasal decongestion improve obstructive sleep apnea? ( Bloch, KE; Clarenbach, CF; Kohler, M; Senn, O; Thurnheer, R, 2008) |
"Nasal obstruction is caused by rebound swelling when the decongestive effect has disappeared." | 1.33 | [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa]. ( Bloching, M; Holzhausen, HJ; Knipping, S; Riederer, A, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mishra, AK | 1 |
Sinha, VR | 1 |
Nilakantan, A | 1 |
Singh, DK | 1 |
Clarenbach, CF | 1 |
Kohler, M | 1 |
Senn, O | 1 |
Thurnheer, R | 1 |
Bloch, KE | 1 |
Caenen, M | 1 |
Hamels, K | 1 |
Deron, P | 1 |
Clement, P | 1 |
Knipping, S | 1 |
Holzhausen, HJ | 1 |
Riederer, A | 1 |
Bloching, M | 1 |
Otten, FW | 2 |
Dolor, RJ | 1 |
Witsell, DL | 1 |
Hellkamp, AS | 1 |
Williams, JW | 1 |
Califf, RM | 1 |
Simel, DL | 1 |
Grote, JJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Does Nasal Decongestion Improve Obstructive Sleep Apnea ?[NCT00630474] | Phase 4 | 12 participants (Actual) | Interventional | 2004-01-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 trials available for xylometazoline and Chronic Disease
Article | Year |
---|---|
Does nasal decongestion improve obstructive sleep apnea?
Topics: Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle A | 2008 |
Comparison of decongestive capacity of xylometazoline and pseudoephedrine with rhinomanometry and MRI.
Topics: Administration, Oral; Administration, Topical; Airway Resistance; Chronic Disease; Ephedrine; Female | 2005 |
Conservative treatment of chronic maxillary sinusitis in children. Long-term follow-up.
Topics: Amoxicillin; Child; Child, Preschool; Chronic Disease; Combined Modality Therapy; Double-Blind Metho | 1997 |
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial.
Topics: Acute Disease; Administration, Intranasal; Adult; Androstadienes; Anti-Inflammatory Agents; Cefuroxi | 2001 |
Otitis media with effusion and chronic upper respiratory tract infection in children: a randomized, placebo-controlled clinical study.
Topics: Amoxicillin; Child; Child, Preschool; Chronic Disease; Combined Modality Therapy; Drainage; Female; | 1990 |
2 other studies available for xylometazoline and Chronic Disease
Article | Year |
---|---|
Rhinosinusitis associated with post-dental extraction chronic oroantral fistula: outcomes of non-surgical management comprising antibiotics and local decongestion therapy.
Topics: Administration, Topical; Adult; Aged; Anesthetics, Local; Anti-Bacterial Agents; Chronic Disease; Fe | 2016 |
[Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
Topics: Administration, Intranasal; Adrenergic alpha-Agonists; Capillary Permeability; Chronic Disease; Dose | 2006 |